Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesThe inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
BMC Immunology, 10/29/09
Brown DP et al. – The authors' results indicate that the inhibitory effects of LILRB4 do not result from a failure to upregulate co–stimulatory proteins. In addition to the high level expression that can render antigen presenting cells tolerogenic, there may be a role for lower level expression and activity of LILRB2 and LILRB4 in response to TLR signalling during an immune response to bacterial infection.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Innate immune responses to influenza A H5N1: friend or foe
Trends in Immunology, 10/30/09
Actinobacteria as mutualists: general healthcare for insects
Trends in Microbiology, 11/04/09
Age dependency and Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients
Journal of Clinical Microbiology, 11/02/09
Today in Other Viral/Bacterial...keeping you current
Receive free subspecialty "5-minute updates" via email
Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey
Nephrology Dialysis Transplantation, 10/30/09
Hyperbaric oxygen therapy as an anti-infective agent
Expert Review of Anti-infective Therapy, 10/21/09
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
JAMA, 11/04/09
Article Search
Sponsor